Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine Plus Herbal Phenolic Monoterpene Fractions for COVID-19
NCT04392141Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Apr 2020
- Primary completion
- Nov 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of colchicine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Mortality Rate. Started Apr 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04392141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392141.